Aisthesis Medical specializes in AI-driven healthcare technology focused on enhancing clinical decision-making
We are thrilled to announce that Aisthesis Medical will be participating in the 37th Annual Congress of the European Society of Intensive Care Medicine (ESICM), taking place from October 5-9 in Barcelona! Our Co-founder and COO, Dr. Vasileios Dimakopoulos, will be presenting an e-poster titled: “The Efficacy of an Explainable AI-driven, Non-Invasive Monitoring System for Early Sepsis Detection.”
Join Us at ESICM
We invite you to join us for the presentation during the "Systemic Inflammation & Sepsis 8" session on Tuesday at 12:45, where we will showcase how our platform, VIOSync, can revolutionize sepsis management. Using advanced multimodal data fusion and Explainable AI (XAI), VIOSync provides early sepsis predictions up to 48 hours in advance, allowing clinicians to intervene sooner and improve patient outcomes.
Why This Matters
Sepsis remains one of the leading causes of mortality in ICUs worldwide, and early intervention is key to reducing its impact. Our e-poster will highlight how VIOSync’s technology empowers clinicians by providing accurate, real-time insights, supporting more effective decision-making, and ultimately saving lives. This is an excellent opportunity to connect with ICU clinicians, sepsis experts, and healthcare leaders who share our mission of leveraging AI to transform critical care.
Let’s Connect!
We’re excited to discuss potential collaborations and partnerships with those passionate about advancing critical care through technology. Let’s explore how VIOSync can streamline clinical workflows, enhance patient monitoring, and redefine sepsis management.
Looking Ahead
We are committed to making a meaningful impact in critical care settings, and ESICM 2024 is an ideal platform to share our advancements, gather feedback, and build new partnerships. Stay tuned as we continue to push the boundaries of healthcare innovation!
See you in Barcelona!
About Aisthesis Medical
Founded in 2022, Aisthesis Medical specializes in AI-driven healthcare technology focused on enhancing clinical decision-making through predictive analytics. Our flagship product, VIOSync, predicts sepsis with 97% accuracy, improving patient outcomes and reducing healthcare costs.